Haloperidol versus olanzapine for people with schizophrenia
- DOI
- 10.1002/14651858.cd013425
- Published
- 2019-10-30
- Container
- Cochrane database of systematic reviews (Online)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/14651858.cd013425,
title = {Haloperidol versus olanzapine for people with schizophrenia},
author = {Khasan Ibragimov and Gregory Keane and Cristina Carreño Glaría and Jie Cheng and Augusto Llosa},
year = {2019},
journal = {Cochrane database of systematic reviews (Online)},
doi = {10.1002/14651858.cd013425},
url = {https://doi.org/10.1002/14651858.cd013425}
}RIS
TY - JOUR TI - Haloperidol versus olanzapine for people with schizophrenia AU - Khasan Ibragimov AU - Gregory Keane AU - Cristina Carreño Glaría AU - Jie Cheng AU - Augusto Llosa PY - 2019 JO - Cochrane database of systematic reviews (Online) DO - 10.1002/14651858.cd013425 UR - https://doi.org/10.1002/14651858.cd013425 ER -
APA
Ibragimov, K., Keane, G., Glaría, C. C., Cheng, J., & Llosa, A. (2019). Haloperidol versus olanzapine for people with schizophrenia. Cochrane database of systematic reviews (Online). https://doi.org/10.1002/14651858.cd013425
Source records
- hal · retrieved 2026-09-25T22:32:25.944Z